e-Therapeutics plc (LON:ETX) will be announcing its earnings results before the market opens on Monday, September 18th.

Shares of e-Therapeutics plc (ETX) opened at 10.75 on Monday. The company’s market capitalization is GBX 28.86 million. e-Therapeutics plc has a 52-week low of GBX 6.00 and a 52-week high of GBX 13.12. The stock’s 50 day moving average is GBX 11.31 and its 200 day moving average is GBX 9.82.

In other news, insider Trevor Mervyn Jones bought 45,364 shares of the firm’s stock in a transaction on Monday, July 3rd. The stock was acquired at an average cost of GBX 1,213 ($15.67) per share, with a total value of £550,265.32 ($710,661.66). Also, insider Iain Gladstone Ross bought 250,000 shares of the firm’s stock in a transaction on Tuesday, August 22nd. The stock was purchased at an average cost of GBX 11 ($0.14) per share, with a total value of £27,500 ($35,515.95).

COPYRIGHT VIOLATION WARNING: “e-Therapeutics plc (ETX) to Release Quarterly Earnings on Monday” was posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2017/09/11/e-therapeutics-plc-etx-to-release-quarterly-earnings-on-monday.html.

e-Therapeutics plc Company Profile

e-Therapeutics plc is a United Kingdom-based drug discovery and development company. The Company’s discovery platform is based on the network of pharmacology and chemical biology. The Company operates in the business segment of drug discovery and development. The Company applies its platform to the discovery of new drug candidates.

Receive News & Ratings for e-Therapeutics plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-Therapeutics plc and related companies with MarketBeat.com's FREE daily email newsletter.